Funding, News and Announcements

The Weston Brain Institute has recently launched its 2018/19 competitions, and a selection can be found below. Please consult the Institute's website for a full list of open and upcoming funding opportunities.

Rapid Response: Canada 2019 (Parkinson’s & Related Diseases)

Seed funding for novel, high-risk, high-reward translational research projects on neurodegenerative diseases of aging. Preliminary data is not required.  Applications in this round must relate to one of the following disease(s): PD, PSP, DLB, MSA, prodromes and/or vascular contributions to these diseases.

Funding Available: Up to $200,000 over up to 18 months.

Project Eligibility: Project must involve the development of either a therapeutic, a tool, select complementary approaches, or a combination of above to help accelerate the development of therapeutics for neurodegenerative diseases of aging.

NEW for 2018/2019: Certain complementary approaches (i.e., diet, physical activity, sleep and nutritional supplements) will be eligible for funding through the Rapid Response program, if applications meet our disease and project scope criteria.

Please see the Request for Applications or visit our website for more information.

Program Information Webinar: June 14, 2018 at 1pm EDT (Register here)
Letter of Intent Deadline: August 1, 2018 at 2pm EDT

Transformational Research: Canada 2019 (Parkinson’s & Related Diseases)

Funding for transformative, novel, high-risk, high-reward translational research projects on neurodegenerative diseases of aging. Applications in this round must relate to one of the following disease(s): Parkinson’s disease, Progressive supranuclear palsy, dementia with Lewy bodies, multiple systems atrophy, prodromes and/or vascular contributions to these diseases.

Funding Available: $200,000 to $1,500,000 over up to 3 years.

Project Eligibility: Project must involve the development of either a therapeutic, a tool, select complementary approaches, or a combination of the above to help accelerate the development of therapeutics for neurodegenerative diseases of aging.

NEW for 2018/2019: Certain complementary approaches (i.e., diet, physical activity, sleep and nutritional supplements) will be eligible for funding through the Transformational Research program, if applications meet our disease and project scope criteria.

Please see the Request for Applications or visit our website for more information.

Program Information Webinar: June 14, 2018 at 1pm EDT (Register here)
LOI Deadline: August 1, 2018 at 2pm EDT

Big Ideas: Canada – call for ideas

The Institute is considering supporting a large-scale, pivotal project to significantly and sustainably advance research in our field. With this call, we are seeking to identify highly impactful ideas for consideration.

Funding Available: $5,000,000 to $20,000,000.

Eligibility: Submissions must:

1. Have a significant and sustained impact on translational research to accelerate the development of therapeutics for neurodegenerative diseases of aging.
2. Be led by Canadian-based researchers.

Please see the Request for Applications or visit our website for more information.

For questions or more information please contact david.spurrell@dal.ca